{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-22-000081","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2022-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.407062+00:00","generated_at":"2026-06-26T05:34:08.722884+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Intuitive Surgical Q1 revenue $1.49B (+15%), GAAP EPS $1.00 vs $1.17 YoY","bullets":["da Vinci procedures grew ~19% YoY; compound annual growth from Q1 2019 was ~15%.","Placed 311 systems (+4% YoY); installed base reached 6,920 systems (+13% YoY).","GAAP net income $366M vs $426M YoY; non-GAAP net income $413M vs $427M.","Cash and investments $8.40B, down $218M in quarter on share repurchases and capex.","Company cited COVID resurgence as headwind but customer demand healthy per CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-22-000081","json":"https://secwatch.observer/filing/0001035267-22-000081.json","markdown":"https://secwatch.observer/filing/0001035267-22-000081.md","text":"https://secwatch.observer/filing/0001035267-22-000081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000081/0001035267-22-000081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000081/isrg-20220421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:34:08.722884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}